Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D administration and plasma renin activity in stable chronic heart failure
2009-015638-31Phase 2Active
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of alfacalcidol in chronic heart failure (CHF) (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Plasma renin activity at 6 weeks. Started Aug 2009; status: active.
02
Drugs
alfacalcidol
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on 2009-015638-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015638-31.